MRD / Regn No. : BNH/23-24/00412 Date : 30/06/2026
Patient Name : DAYANAND A Age & Gender : 67 Yrs. / Male
Contact No. : 9880214001 UHID :
Ht / Wt / BMI : / 76 / BP S / BP D : 120 / 75
Allergies : NIL Referred By :
   
Subjective : ,ASYMPTOMATIC,SEDENTARY LAST 2 MONTHS,S/P PTCA/ STENTING TO CALCIFIED RCA IN 2023
Analysis : HBA1C-5.6,TOTAL CHOLESTEROL-118,TRIGLYCERIDES-254,HDL CHOLESTEROL-20,LDL CHOLESTEROL-47,03/02/26,CHOLESTEROL-114,TRIGLYCERIDES-137,HDL-28,LDL-58,CREATININE-0.9,HBA1C-5.2,LP[A]-40.26,30/06/26,FBS-105,HBA1C-5.4,CREATININE-0.8,CHOLESTEROL-109,TRIGLYCERIDES-182,HDL-27,LDL-45,LP[A]-33.1,UACR-29 MG
S# Generic (Trade) Name Route Dosage Usage Duration
1 BISOJOY 2.5 MG ORAL 1-0-0 AFER FOOD
2 CAPSULE ALFUZOSIN , DUTASTERIDE
AFDURA
ORAL 1-0-0 AFER FOOD
TILL NEXT VISIT
3 NOVASTAT CV 20 MG ORAL 0-0-1 AFER FOOD
4 TADALAFIL CITRATE 5 MG
MODULA 5 MG
Medicine For ERECTILE DYSFUNCTION
ORAL 1-0-0 AFTER FOOD
TILL NEXT VISIT
NOT TO BE TAKEN IF WITH NITRATE GROUP OF DRUGS (HEART)
5 ICOS 1GM ORAL 1-0-0 AFER FOOD
       
Refill : 0 / Substitution:    
Education :
Next Visit : 28/Oct/2026
Tests Suggested For Next Visit : FASTING LIPID PROFILE. HBA1C,SERUM CREATININE,X 4 MONTHS
   
   

Dr. V. S. Prakash
MD, DM, FISE, FSCAI, FACC, FESC
Karnataka / 21756

This is a Computer generated Prescription

Powered By: